protein 39 (Cab39, also known as MO25α). 6 Although several lines of evidence indicate that AMPK phosphorylation is attenuated in diet-induced obesity (DIO) mouse hearts, 7, 8 the mechanisms by which AMPK phosphorylation is decreased are not fully understood.
MicroRNAs (miRNAs or miRs) are a large class of small noncoding RNAs. miRNAs suppress the translation of a target mRNA depending on the complementarity between the 5′ side seed sequence of a miRNA and the 3′ untranslated region (3′UTR) of the target mRNA. Although several reports indicate that miRNAs are involved in diabetic cardiomyopathy in a type 1 DM model of streptozotocin-induced diabetic mice, [9] [10] [11] miRNA functions in diabetic hearts induced especially by type 2 DM remain to be elucidated.
In the present study, we used DIO mice to identify differentially regulated miRNAs in hearts. One of these miRNAs, miR-451, was upregulated in the hearts, and palmitic acid stimulation increased miR-451 levels in neonatal rat cardiac myocytes (NRCMs). miR-451 directly targeted Cab39 in NRCMs, and loss of miR-451 function partly rescued lipotoxicity in vitro. Furthermore, we revealed that high-fat diet (HFD)-induced cardiac hypertrophy was ameliorated in cardiomyocyte-specific miR-451 knockout (miR-451 cKO) mice. Finally, we showed that AMPK phosphorylation was increased and mammalian target of rapamycin (mTOR) phosphorylation was decreased in the HFD-fed miR-451 cKO mice compared with the HFD-fed control mice. These data strongly suggest that cardiac-specific inhibition of miR-451 is a strategy for treating diabetic cardiomyopathy.
Methods
Detailed methods are provided in the Online Data Supplement.
Results

miRNA-451 Expression Is Significantly Increased in DIO Mouse Hearts
To clarify miRNA expression changes in DIO mouse hearts, we used HFD-fed C57BL/6 mice. This is a well-established obesity and type 2 DM model, 12 and the C57BL/6 mice become obese depending on the duration of HFD feeding, as shown in Figure 1A . In line with our and other reports, 8, 12, 13 liver weights approximately doubled, and fasting blood sugar concentrations increased significantly by 1.5-fold after feeding 45 kcal% fat-containing HFD for 20 weeks ( Figure 1B and 1C). These data suggest that this mouse model had marked insulin resistance and fatty liver and mimicked obesity with type 2 DM in humans.
To evaluate miRNA expression changes in the heart, we performed microarray analyses of miRNAs extracted from the hearts of mice fed HFD for 8 and 20 weeks. We focused on miRNAs meeting the following 3 criteria. The miRNA was evidently expressed in the heart (miRNA spot intensity, >100), the expression levels increased depending on the duration of HFD feeding, and the levels were 2-fold higher than those in control mouse hearts. Only miR-451 met these criteria (Online Figure 1D ). As shown in Figure 1E , miR-451 expression levels were validated using Taqman microRNA realtime polymerase chain reaction (PCR). These data suggest that only miR-451 levels were significantly increased in DIO mouse hearts. It is reported that miR-451 and miR-144 are transcribed as a bicistronic transcript to yield 2 mature miR-NAs. 14, 15 Therefore, we also evaluated miR-144 levels in the microarray analysis. Interestingly, the spot intensity of miR-144 was extraordinarily lower than that of miR-451 (Online Figure I and Figure 1D ). Because saturated FAs, such as palmitic acid, are one of the mediators of lipotoxicity, 4 we measured the plasma concentrations of total palmitic acid in the normal chow (NC)-fed and HFD-fed mice. The plasma concentration of total palmitic acid was significantly higher in the HFD-fed mice compared with the NC-fed mice ( Figure 1F ). Because we did not remove lipoproteins from plasma, which contain considerable amounts of triglycerides, we evaluated palmitic acid incorporated within apoB-containing lipoproteins, such as very-low-density lipoprotein and low-density lipoprotein. After precipitation with a polyethyleneglycol solution, the palmitic acid levels in serum samples of NC-fed mouse were significantly reduced, as shown in Online Figure II.
Figure I and
miR-451 Expression Is Induced by Palmitic Acid Stimulation, and Elevated miR-451 Causes Cell Toxicity in NRCMs
miR-451 is expressed abundantly in blood cells, such as erythrocytes and macrophages. [14] [15] [16] Thus, we sought to isolate cardiac myocytes and cardiac fibroblasts and determine whether miR-451 is expressed in these cells. Cardiac myocytes do not have cell surface-specific markers, and a report indicated that cardiac myocytes have higher mitochondrial content than non-cardiac myocytes and could be purified by mitochondrialabeling dyes. 17 To mark cardiac fibroblasts, we used allophycocyanin-conjugated Thy-1.2 antibody. As shown in Online Figure IIIA , isolated cells from neonatal mouse ventricles were analyzed and sorted by fluorescent-activated cell sorting. In line with a previous study, the mRNA levels of brain natriuretic peptide were significantly higher in the populations with high Mitotracker Green fluorescent content and negative Thy-1.2 (Mito high /Thy-1.2 neg ) than in populations with low Mitotracker Green fluorescent content and positive Thy-1.2 (Mito low /Thy-1.2 posi ; Online Figure IIIB) , indicating that the Mito high /Thy-1.2 neg populations contain many cardiac myocytes. 17 Whereas the mRNA levels of collagen type 1 α1 were significantly higher in Mito low /Thy-1.2 posi populations than in Mito high /Thy-1.2 neg populations (Online Figure IIIC) , indicating that cardiac fibroblasts comprise Mito low /Thy-1.2 posi populations. miR-451 levels were significantly higher in cardiac myocytes than in cardiac fibroblasts (Online Figure IIID) , which suggested that miR-451 was expressed in cardiac myocytes. In addition, we tried to compare the miR-451 levels in cardiac myocytes and erythrocytes. We collected peripheral blood from a neonatal mouse, and fluorescent-activated cell sorting sorted erythrocytes that were labeled with an anti-Ter119 antibody, a marker of erythrocytes (Online Figure IVA) . Because the total RNA mass extracted from erythrocytes was extremely low, and the U6 level was also lower than that in cardiac myocytes, we did not think that U6 was suitable for use as an internal control in erythrocytes. Thus, the miR-451 level per cell was determined from a standard curve for artificial miR-451, the total RNA mass obtained, and the numbers of cells collected by fluorescent-activated cell sorting. The miR-451 levels in cardiac myocytes were ≈40-fold higher than those in erythrocytes (Online Figure IVB) . These data were consistent with those in a previous report. 18 Thus, we attempted to investigate miR-451 functions in cardiac myocytes. We next stimulated NRCMs with palmitate to determine whether this induced miR-451 expression in cardiac myocytes as both albumin-bound FAs and FAs incorporated within lipoproteins are used as fuel by cardiac myocytes, 19, 20 and the total palmitic acid concentration was significantly higher in the plasma of HFD-fed mice than in that of NC-fed mice ( Figure 1F ). As shown in Figure 2A and 2B, palmitate stimulation resulted in elevated miR-451 levels in a dose-and timedependent manner. We also measured the expression levels of miRNAs expressed abundantly in muscle cells, including miR-133a, miR-208a, and miR-499, but we did not observe any significant increases in their levels ( Figure 2B ). In addition, we assessed the effects of oleic acid, an unsaturated FA, on miR-451 expression in NRCMs. Our data indicated that the total oleic acid level in plasma was approximately one half of the total palmitic acid level (data not shown). Thus, we stimulated NRCMs with oleic acid at 250 μmol/L. Although miR-451 level was also upregulated by oleic acid, this increase was modest; and the miR-451 upregulation by oleic acid was significantly lower than that by palmitic acid at 250 μmol/L (Online Figure VA) .
We then overexpressed miR-451 in NRCMs using a lentiviral system to elucidate miR-451 functions. Although the miR-451 level was high in NRCMs infected with a miR-451 expression vector (Online Figure VI) , cell survival was significantly reduced after miR-451 overexpression ( Figure 2C ). Palmitate stimulation caused miR-451 upregulation in NRCMs, and ectopic expression of miR-451 induced cell toxicity; therefore, we hypothesized that miR-451 knockdown would ameliorate palmitate-induced cell toxicity. miR-451 decoys were induced in NRCMs, and these NRCMs were stimulated with palmitate. We found that cell injury measured by the lactate dehydrogenase assay was partly rescued ( Figure 2D ). To clarify the induction of miR-451 and lipotoxicity in NRCMs at physiological ratios of palmitate to albumin, the albumin concentration was fixed at 550 μmol/L and NRCMs were stimulated with various concentrations of palmitate. miR-451 levels were significantly upregulated at palmitate to albumin ratios of 1:2 and 1:1 ( Figure 2E ). Palmitate-induced lipotoxicity was observed at a ratio of 1:2, and the lipotoxicity was significantly ameliorated when miR-451 was knocked down ( Figure 2F ). These data imply that palmitate induces miR-451, and the elevation in miR-451 levels in part exacerbates lipotoxicity in NRCMs.
Cab39 Is a Direct Target of miR-451 in NRCMs and Mice
We next sought to identify the target of miR-451 in cardiac myocytes. To date, macrophage inhibitory factor (MIF), 21 Cab39, 22 14-3-3ζ, 15 CUG triplet repeat-binding protein 2, 23 and Ras-related C3 botulinum toxin substrate 1 14 have been January 16, 2015 identified as direct miR-451 targets. Of these bona fide targets, we focused on 2 proteins that have cell protective functions, MIF 24 and Cab39, 5, 22 because our data indicate that miR-451 knockdown ameliorates palmitate-induced lipotoxicity. To examine whether miR-451 can directly bind to the 3′UTRs of MIF and Cab39, wild-type (WT) or mutated (Mut) miR-451-binding sites of MIF or Cab39 were inserted into the 3′UTR of a luciferase plasmid, and we performed dual luciferase assays in 293T cells. As shown in Online Figure VIIA and Figure 3A , luciferase activities were significantly decreased when miR-451 was co-overexpressed with luciferase plasmids harboring WT MIF-3′UTR or Cab39-3′UTR. This decrease was abolished when Mut MIF-3′UTR or Cab39-3′UTR luciferase plasmids were cotransfected with the miR-451 overexpression plasmid. Western blotting analysis revealed that miR-451 overexpression reduced MIF and Cab39 protein levels in NRCMs (Online Figure VIIB ; Figure 3B ). These data indicate that MIF and Cab39 are direct targets of miR-451 in NRCMs. We also evaluated MIF and Cab39 protein levels in vivo. Although we did not observe a reduction in the MIF protein level, the Cab39 protein level in the hearts was decreased in the 45 kcal%-containing HFD-fed mice compared with the NC-fed mice (Online Figure VIIC and Figure 3C ). Thus, we focused on Cab39. To strengthen the finding that Cab39 is a target of miR-451 in NRCMs, we attempted to rescue miR-451-induced cell toxicity by Cab39 overexpression. As shown in Figure 3D , Cab39 overexpression rescued miR-451-induced cell toxicity. Furthermore, Cab39 overexpression ameliorated cell toxicity in palmitate-stimulated NRCMs ( Figure 3E ). Together, these data suggest that palmitic acid stimulation upregulates miR-451 expression, which reduces Cab39 levels, resulting in cell toxicity.
Cab39 is a scaffold protein of LKB1 that stabilizes the activity through the formation of a heterotrimeric complex with ste20-related adaptor in the cytoplasm. 6 It is well established that LKB1 is an upstream kinase of AMPK. To verify the significance of the LKB1/AMPK pathway in NRCMs, we performed immunoblotting for AMPK. After palmitate stimulation, AMPK phosphorylation in NRCMs was significantly decreased ( Figure 3F ). To determine the specificity of palmitic acid on AMPK phosphorylation, we stimulated NRCMs with oleic acid. Suppression of AMPK phosphorylation was not observed even with oleic acid at 500 μmol/L (Online Figure  VB and VC). Furthermore, we evaluated Cab39 protein levels and AMPK phosphorylation in vivo. Western blotting analysis revealed that AMPK phosphorylation was reduced in the hearts of mice fed 45 kcal% fat-containing HFD for 20 weeks in association with the decrease of Cab39 ( Figure 3C ).
miR-451 cKO Mice Attenuated HFD-Induced Cardiac Hypertrophy
We required miR-451 knockout mice to reveal miR-451 functions in the HFD-fed mouse hearts. miR-451 is transcribed with miR-144 as a bicistronic transcript. O'Carroll and colleagues 14 reported that miR-144 and miR-451 double knockout (miR-144/451 −/− ) mice show ineffective erythropoiesis and mild anemia, and the phenotype of miR-451 single knockout mice was fairly distinguishable from that of the miR-144/451 −/− mice. 15 We thought that anemia induced by miR-451 deletion could affect the phenotype in the hearts of the HFD-fed mice. Thus, we crossed the α-myosin heavy chain (αMHC)-Cre transgenic mice and floxed miR-451 mice to generate the αMHC-Cre;miR-451 fl/fl or miR-451 cKO mice. To eliminate the direct effect of Cre-recombinase in cardiac myocytes, αMHC-Cre;miR-451 +/+ mice were used as the control mice. We attempted to validate the manipulation of the miR-451 locus in the genome using PCR analysis. As shown in Online Figure VIII , WT miR-451 and floxed miR-451 could be detected as bands of 393 and 580 nucleotides, respectively. When we performed PCR using DNA extracted from the miR-451 cKO mouse hearts as a template, we observed ablated Figure 2 . Lipotoxicity is partly because of microRNA (miR)-451, which is upregulated by palmitic acid stimulation in neonatal rat cardiomyocytes (NRCMs). A, miR-451 levels after palmitic acid stimulation for 24 hours in NRCMs, n=4 to 6. B, miR-451, miR-133a, miR-208a, and miR-499 levels in palmitate-stimulated NRCMs, n=3. C, Cell viability of NRCMs transfected with the miR-451 overexpression vector, n=4. D, Cell injury evaluation using lactate dehydrogenase (LDH) assays in miR-451 decoy-introduced NRCMs. These NRCMs were stimulated with palmitate for 24 hours, n=3 to 4. E, miR-451 levels in NRCMs stimulated for 48 hours with various palmitate to albumin ratios. Albumin concentration was fixed at 550 μmol/L, n=6 to 12. F, Cell injury was evaluated using LDH assays in miR-451 decoy-introduced NRCMs. These NRCMs were stimulated for 72 hours with the indicated palmitate and albumin concentrations, n=4. Data are presented as mean±SEM. *P<0.05; **P<0.01; ***P<0.001. AU indicates arbitrary unit. miR-451 as an ≈250-nucleotide long band. A nonablated band was also observed after PCR analysis of heart DNA from the miR-451 cKO mice. We assumed the reason was that floxed miR-451 remained in non-cardiac myocytes.
The αMHC-Cre;miR-451 fl/fl and αMHC-Cre;miR-451 +/+ mice started feeding on NC or 60 kcal% fat-containing HFD when they were 8 weeks old and were fed on their respective diets until the age of 28 weeks. No differences were found in body weights, liver weights, or fasting blood sugar concentrations between the NC-or HFD-fed control and miR-451 cKO mice ( Figure 4A ; Online Figure IXA and IXB) . The miR-451 levels showed a clear declining trend in the NC-fed miR-451 cKO mice ( Figure 4B ), and the levels in the hearts were significantly increased in the HFD-fed control mice compared with the NC-fed control mice. As expected, this miR-451 upregulation in hearts was not observed in the HFD-fed miR-451 cKO mice.
Because it was reported that GATA4 regulated miR-451 expression in cardiac myocytes, 25 we performed Western blotting for GATA4 to identify the mechanism by which miR-451 was upregulated in HFD-fed mouse hearts. As shown in Online Figure XA and XB, protein levels of GATA4 were significantly increased in HFD-fed mouse hearts. This upregulated GATA4 may have induced miR-451 in HFD-fed mouse hearts.
In agreement with a previous report, 13 the heart weight and the ratio of heart weight-to-tibial length were significantly increased in the HFD-fed control mice compared with the NCfed control mice (Online Figure IXC; Figure 4C ). The ratio of heart weight-to-tibial length was significantly decreased in the HFD-fed miR-451 cKO mice compared with in the HFDfed control mice ( Figure 4C ). Transthoracic echocardiography also revealed that left ventricular wall thickness was significantly reduced in the HFD-fed miR-451 cKO mice compared with the HFD-fed control mice ( Figure 4D ; Online Figure  IXD) , although cardiac functions were not different between the HFD-fed control and miR-451 cKO mice at steady state (data not shown). Representative lectin staining of crosssections of ventricles is shown in Figure 4E . Quantification of lectin staining revealed that HFD-induced cardiac hypertrophy was noticeably diminished in the miR-451 cKO mice compared with the control mice ( Figure 4F ). Because miR-451 overexpression caused cell toxicity in NRCMs, we performed Western blotting for cleaved caspase-3 and single strand DNA staining to evaluate cell toxicity in vivo. We did not detect cleaved caspase-3 (Online Figure XIA) and there was no difference in single strand DNA-positive cardiac myocytes (Online Figure XIB-XIE) . To evaluate fibrosis, we also performed picrosirius red staining and quantitative reverse transcription PCR. However, we did not observe a significant difference in fibrosis area and collagen type 1 α1 mRNA levels between the HFD-fed miR-451 cKO and control mice (Online Figure XII) . These data suggest that HFD-induced cardiac hypertrophy is ameliorated in the miR-451 cKO mice.
AMPK Phosphorylation in the Heart Is Strengthened in HFD-Fed miR-451 cKO Mice
Western blotting analysis was performed to determine the signaling pathways activated in the control and miR-451 cKO mouse hearts. As expected, Cab39 protein levels in the hearts were significantly increased in the HFD-fed miR-451 cKO mice compared with the HFD-fed control mice ( Figure 5A ). AMPK phosphorylation at Thr 172 , a downstream target of the Cab39/LKB1 complex, was also substantially enhanced in the hearts of the HFD-fed miR-451 cKO mice compared with the HFD-fed control mice ( Figure 5B ). Next, we evaluated the phosphorylation of mTOR, a regulator of protein synthesis, 26 and S6 ribosomal protein, which is a substrate of S6 kinase-a downstream target of mTOR. mTOR phosphorylation and S6 phosphorylation were significantly suppressed in the HFD-fed miR-451 cKO mice compared with the HFD-fed control mice ( Figure 5C and 5D ). Because AMPK suppresses mTOR signaling, 26 these data suggested that HFD-induced cardiac hypertrophy was attenuated, at least in part, via the 
Accumulation of Lipid Intermediates and Reactive Oxygen Species Production
Previous reports have shown that several lipid intermediates, such as triglyceride and ceramide, may be cell toxic for cardiac myocytes. 8, 27 Thus, we evaluated the accumulation of neutral lipid using BODIPY 505/515 staining. We detected small green droplets in cardiac myocytes. However, we did not observe any differences in the accumulation between HFD-fed control mouse hearts and HFD-fed cKO mouse hearts (Online Figure XIIIA-XIIID) . We next performed immunohistochemistry for ceramide 8 and quantified ceramide content in the hearts. Long-term HFD feeding resulted in ceramide accumulation in control mouse hearts, whereas this accumulation was reduced in miR-451 cKO mouse hearts ( Figure 6A-6C ). Furthermore, we attempted to analyze the levels of reactive oxygen species (ROS). It has been reported that ROS peroxidize ω-6 unsaturated FAs and generate 4-hydroxy-2-nonenal, an aldehyde. The 4-hydroxy-2-nonenal binds to proteins and composes 4-hydroxy-2-nonenal adducts. 28 Interestingly, Western blotting for 4-hydroxy-2-nonenal adducts revealed that ROS levels were higher in HFD-fed miR-451 cKO mouse hearts than in HFD-fed control mouse hearts ( Figure 6D ). We also performed dihydroethidium staining. As shown in Figure 6E and 6F, dihydroethidium fluorescence intensity was significantly increased in HFD-fed miR-451 cKO mice compared with HFD-fed control mice. These data suggest that ROS levels are significantly increased in HFD-fed miR-451 cKO mouse hearts compared with HFD-fed control mouse hearts.
Functional Changes in HFD-Fed miR-451 cKO Mouse Hearts
Finally, we sought to reveal the functional changes in the hearts. Cardiac stress was induced by dobutamine infusion and was monitored by cardiac catheterization. We found that the contractile reserve was reduced in HFD-fed control mouse heart compared with NC-fed control mouse heart, in line with a previous report 13 (Figure 7A ), although no difference in diastolic reserve was observed ( Figure 7B ). The reduced contractile reserve was ameliorated, at least in part, in the HFD-fed miR-451 cKO mouse hearts, as shown in Figure 7A .
Discussion
Our data suggest that miR-451 is involved in diabetic cardiomyopathy. Only miR-451 was upregulated in our type 2 DM model mice, and this was dependent on the duration of HFD feeding. Lu et al 29 found that miR-223 is differentially regulated in the cardiac tissue of patients with type 2 DM. To date, most researchers have used streptozotocin-induced diabetic mice to investigate miRNA involvement in diabetic cardiomyopathy. [9] [10] [11] Although Shen et al 10 used real-time PCR to validate 16 miRNAs identified by microarray analysis, the number of dysregulated miRNAs was small in DIO mouse hearts, a type 2 DM model. We considered that this was the case for 2 reasons. First, changes in miRNA expression levels associated with diabetic cardiomyopathy are dependent on the type of diabetes mellitus. Secretion defects of insulin and insulin resistance may invoke different miRNA changes in the heart. Second, the duration of HFD feeding may have been relatively short. To evaluate these possibilities, C57BL/6 mice fed HFD for a longer period or genetically manipulated mice, such as ob/ob or db/db mice, may be needed.
Because miR-144 and miR-451 are transcribed as a bicistronic transcript, 14, 15 it was surprising that miR-144 expression was unchanged in DIO mouse hearts. Considering our microarray results, miR-451 levels in the hearts were noticeably higher than miR-144 levels. We hypothesize that miR-451 may be more stable than miR-144 and miR-144 may be more fragile than miR-451, at least in hearts. It was reported that miR-144/451 double knockout mice showed insufficient maturation of erythrocytes, resulting in mild anemia, and the phenotypes of the miR-144/451 double knockout mice and miR-451 single knockout mice were almost indistinguishable. 14 These results suggest that miR-451 is functionally dominant compared with miR-144, at least in bone marrow. Furthermore, it was shown that miR-451 biogenesis was Dicer independent and required Argonaute2 catalytic activity. 16 Taken together, the evidence indicates that miR-451 plays more important roles in the heart than miR-144, and post-transcriptional regulation of miR-451 expression may be altered in diabetic hearts.
Our data indicate that palmitic acid induced miR-451 upregulation in NRCMs. How is miR-451 expression regulated? Many reports showed that palmitic acid enhances nuclear factor κB signaling 3, 30 ; therefore, 1 possible mechanism is that activation of inflammation signaling, including nuclear factor κB, induces miR-451. Others indicated that the miR-144/451 cluster was directly regulated by GATA4. 25 Numerous reports suggest that GATA4 plays a pivotal role in cardiac hypertrophy in vitro and in vivo; therefore, GATA4 may regulate miR-451 levels in HFD-induced hypertrophic hearts. Indeed, we observed the upregulation of GATA4 in HFD-fed mouse hearts. Recent reports demonstrated that activation of farnesoid X receptor (FXR) increased miR-144 and miR-451 levels in the liver. 31 The nuclear receptor FXR regulates genes involved in the synthesis, secretion, and resorption of bile acids. Although abundant FXR expression is observed in the liver, intestine, kidney, and adrenal grand, bile acids are endogenous ligands for FXR, and some reports suggest that bile acid levels in serum are increased in obese or type 2 DM mice and humans. 32, 33 Hence, another possible mechanism is that bile acid-activated FXR induces miR-451 expression. Further studies are required to elucidate the transcription factors that regulate miR-451 expression.
Clinical data indicated that obesity and type 2 DM are linked to cardiac hypertrophy independently of blood pressure. 34 The present study and others show that long-term feeding of HFD to C57BL/6 mice results in cardiac hypertrophy. 13, 35 The phenotypes of HFD-induced obesity mouse hearts were similar to those of cardiomyocyte-specific LKB1 knockout (LKB1 cKO) mouse hearts. Ikeda et al reported that the ventricular weight-to-body weight ratio was significantly increased in the LKB1 cKO mice at 12 weeks of age compared with the control mice and fibrosis markers in cardiac ventricles were not different between the LKB1 cKO mice and control mice. 36 Our data strongly support that HFD-induced cardiac hypertrophy is partly because of decreased Cab39 levels through miR-451 upregulation. Collectively, the evidence indicates that miR-451 downregulation is a therapeutic strategy to attenuate HFD-induced cardiac hypertrophy.
Our data show that miR-451 overexpression resulted in cell toxicity, and miR-451 knockdown attenuated palmitateinduced lipotoxicity. Thus, to clarify the direct targets of miR-451, we focused on MIF and Cab39, which have cell protective functions. 5, 22, 24 Our results show that the LKB1/AMPK signaling pathway plays a protective role in HFD-induced cardiac hypertrophy. These data are consistent with those of another report, which indicated that AMPK deficiency exacerbates obesity-induced cardiac hypertrophy. 35 Also, it is reported that miR-451 levels are significantly increased in the hearts of a hypertrophic cardiomyopathy mouse model and are involved in Cab39 expression in C2C12 cells. 18 However, other unrecognized direct targets of miR-451 may be involved in diabetic cardiomyopathy because growing evidence suggests that miRNAs have large numbers of direct targets.
We used 45 kcal% fat-containing HFD-fed animals to screen dysregulated miRNAs in DIO mouse hearts. C57BL/6 mice were fed 45 kcal% fat-containing HFD for 20 weeks, and we identified miR-451 levels as being markedly increased by ≈2-fold. Because palmitic acid stimulation increased miR-451 levels in a dose-dependent manner in NRCMs, miR-451 cKO mice were fed 60 kcal% fat-containing HFD for increasing the FA supply to the heart. However, the miR-451 levels increased by ≈1.5-fold, and we did not observe further miR-451 upregulation in the 60 kcal% fat-containing HFD-fed mice compared with the 45 kcal% fat-containing HFD-fed mice. Compensatory mechanisms may inhibit the additional increase in miR-451 expression in vivo.
Cab39 also stabilizes other STE20 family kinases, ste20related proline alanine-rich kinase and oxidative stress-responsive kinase, in a manner similar to ste20-related adaptor. These kinases function mainly in the kidney, but these kinases or other Cab39-binding proteins may attenuate diabetic cardiomyopathy. LKB1 also targets members of an AMPKrelated superfamily. 37 To date, the functions of these peptides in the hearts remain unknown. Because it is possible that these peptides are also involved in HFD-induced cardiac hypertrophy, further investigations are needed to clarify the exact mechanisms.
In the present study, we demonstrated that ROS levels were higher in HFD-fed miR-451 cKO mouse hearts than in HFDfed control mouse hearts. Many reports have shown that ROS levels are increased in type 2 diabetes mellitus, and that these ROS are harmful. Under these conditions, AMPK phosphorylation is usually suppressed. However, based on our data, the AMPK-induced ROS or ROS in AMPK-unsuppressed situations may be protective. This concept is consistent with the results in a previous report, 38 which shows that increased mitochondrial function and superoxide production increased by AMPK activation are beneficial in diabetic kidney disease. In addition, it has been reported that some types of ROS may play protective role and suppress inflammation in autoimmune disease. 39 Thus, the relationship between ROS and AMPK warrants further investigation.
LKB1 is recognized as a tumor suppressor gene, and loss of LKB1 function causes Peutz-Jeghers syndrome. Patients predisposed to this syndrome develop early-onset polyposis throughout the entire gastrointestinal tract and are at increased risk for developing cancer at a relatively young age. It was also reported that obesity increases the risk of cancer as well as cardiovascular disease. Hence, we speculate that miR-451 expression is induced in the gastrointestinal epithelium in obese patients. If so, attenuated LKB1 activity could increase the risk of gastrointestinal cancer. This hypothesis is fascinating because miR-451-targeted therapy may be able to prevent gastrointestinal cancer. Indeed, it has been proposed that increased miR-451 levels increase cell proliferation. 40 In conclusion, miR-451 levels were markedly increased in palmitate-stimulated NRCMs and DIO mouse hearts. We found that Cab39 was a direct target of miR-451 in the heart. miR-451 knockdown partly rescued lipotoxicity in vitro, and HFD-induced cardiac hypertrophy was ameliorated in miR-451 cKO mice through the LKB1/AMPK pathway. Thus, cardiac-specific inhibition of miR-451 is a promising strategy for treating diabetic cardiomyopathy.
